Trabeculitis refers to an inflammatory process affecting the trabecular meshwork, a porous, sponge-like tissue located in the anterior chamber angle of the eye that facilitates the outflow of aqueous humor from the eye into the bloodstream via Schlemm’s canal. This inflammation can impair drainage, resulting in increased intraocular pressure (IOP), which may progress to secondary open-angle glaucoma if untreated. It is commonly associated with infectious or inflammatory conditions, such as viral infections (e.g., herpes simplex or varicella-zoster virus), uveitis, or trauma.
Key features and pathophysiology include:
Mechanism: Inflammation causes edema, thickening of trabecular beams, accumulation of inflammatory cells (e.g., lymphocytes, macrophages), or keratic precipitates on the meshwork, obstructing aqueous outflow. This can be acute or chronic, often presenting with symptoms like eye pain, redness, blurred vision, halos around lights, or photophobia.
Etiologies: Frequently viral (herpetic trabeculitis), but can also stem from bacterial infections, tuberculosis, syphilis, trauma (e.g., angle recession), or autoimmune uveitis. In herpetic cases, viral replication in the trabecular endothelium triggers an immune response.
Diagnosis: Confirmed via gonioscopy (visualizing keratic precipitates or angle abnormalities), slit-lamp examination, tonometry (measuring IOP), and sometimes anterior segment optical coherence tomography (OCT). Laboratory tests may include PCR for viral DNA or serology for underlying infections.
Complications: Untreated, it can lead to chronic glaucoma, optic nerve damage, visual field loss, or synechiae formation (adhesions in the angle).
Treatment: Depends on the cause; includes topical corticosteroids to reduce inflammation, antiviral agents (e.g., acyclovir for herpetic cases), IOP-lowering medications (e.g., beta-blockers, prostaglandin analogs), or surgical interventions like trabeculectomy in refractory cases. Prognosis is good with early intervention, but recurrent episodes can cause permanent damage.
Epidemiology: Rare as a primary condition; more common in association with anterior uveitis (affecting 5-20% of uveitis cases with glaucoma). It typically affects adults, with higher incidence in those with immunocompromise or prior ocular herpes. This condition underscores the link between ocular inflammation and glaucoma, requiring multidisciplinary management by ophthalmologists.
latin - Trabeculitis: Derived from Latin “trabecula” (diminutive of “trabs,” meaning “beam” or “timber”), referring to the beam-like or lattice structure of the trabecular meshwork, which resembles small supporting beams. The suffix “-itis” comes from Greek “-îtis,” indicating “inflammation.” Thus, “trabeculitis” literally means “inflammation of the small beams” (in the context of the eye’s drainage system).
The term emerged in medical literature in the mid-20th century with advances in gonioscopy and understanding of glaucoma pathophysiology, though “trabecular” structures were described as early as the 19th century by anatomists like Friedrich Schlemm (note: etymology of “ophthalmology” indirectly relates, but specific to trabecula).
Similar conditions: Pigmentary glaucoma (pigment dispersion in meshwork), pseudoexfoliation syndrome (material deposition), angle-closure glaucoma (distinct mechanism but related IOP elevation)
CODING NUANCES
ICD-10-CM Diagnosis Codes:
H40.40X0 Glaucoma secondary to eye inflammation, unspecified eye, stage unspecified
H40.41X0 Glaucoma secondary to eye inflammation, right eye, stage unspecified
H40.42X0 Glaucoma secondary to eye inflammation, left eye, stage unspecified
H40.43X0 Glaucoma secondary to eye inflammation, bilateral, stage unspecified
H20.9 Unspecified iridocyclitis|Use for uveitis-related trabeculitis
H40.1- Open-angle glaucoma; If leading to glaucoma
H40.89 Other specified glaucoma; For trabeculitis-induced IOP rise